147 results on '"Miyajima, Akira"'
Search Results
2. The Conditional Survival with Time of Intravesical Recurrence of Upper Tract Urothelial Carcinoma
3. Determining When to Stop Prostate Specific Antigen Monitoring after Radical Prostatectomy: the Role of Ultrasensitive Prostate Specific Antigen
4. Preoperative Hydronephrosis Grade Independently Predicts Worse Pathological Outcomes in Patients Undergoing Nephroureterectomy for Upper Tract Urothelial Carcinoma
5. Long-Term Androgen Ablation and Docetaxel Up-Regulate Phosphorylated Akt in Castration Resistant Prostate Cancer
6. A NEW STRATEGY FOR THE TREATMENT OF PROSTATE CANCER BY TARGETING VASOHIBIN-2: MP90-09
7. REACTIVE OXYGEN SPECIES INDUCTION BY CABAZITAXEL VIA INHIBITION OF THE SESTRIN FAMILY IN CASTRATION-RESISTANT PROSTATE CANCER: MP90-03
8. BIOINFORMATIC ANALYSIS UTILIZING THE ANDROGENIC SUPPRESSIVE EFFECT IDENTIFIED PROMISING CANDIDATE DRUGS FOR REPROGRAMMING DOCETAXEL-RESISTANT CASTRATION-RESISTANT PROSTATE CANCER: MP84-20
9. SIMPLE AND PRACTICAL NOMOGRAMS FOR PREDICTING STONE-FREE RATE AFTER EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY IN PATIENTS WITH SOLITARY STONE IN UPPER URINARY TRACT: MP54-04
10. ARE THERE ANY APPROPRIATE CRITERIA FOR RECOMMENDING PROSTATE BIOPSY IN PATIENTS OVER 75 YEARS OLD?: MP39-20
11. LONG-TERM FOLLOW-UP DATA AFTER RADICAL PROSTATECTOMY: DETERMINING WHEN TO STOP PSA MONITORING: MP40-07
12. IMPACT OF MAXIMUM TUMOR DIAMETER ADJUSTED BY PRIMARY TUMOR LOCATION IN PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA MANAGED BY RADICAL NEPHROURETERECTOMY: THE MULTI-INSTITUTIONAL STUDY: MP27-18
13. PROGNOSTIC ROLE OF PROGRAMMED CELL DEATH PROTEIN 1 EXPRESSION IN SURGICALLY TREATED PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA.: MP27-02
14. ARE CALCULATED FORMULAS FOR ESTIMATING RENAL FUNCTION ADEQUATE FOR ADMINISTERED CISPLATIN-BASED CHEMOTHERAPY IN SOLITARY RENAL PATIENTS AFTER NEPHROURETERECTOMY FOR UPPER TRACT UROTHELIAL CARCINOMA?: MP27-05
15. EXTERNAL VALIDATION OF PROGNOSTIC IMPACT OF PATIENT AGE AND GENDER IN PATIENTS TREATED WITH RADICAL NEPHROURETERECTOMY: PROPOSED NEW PERSPECTIVE OF GENDER-ADJUSTED AGE IN UPPER TRACT UROTHELIAL CARCINOMA: PD13-12
16. CHARACTERIZING INTERMEDIATE-RISK NON-MUSCLE INVASIVE BLADDER CANCER: IMPLICATIONS FOR THE DEFINITION OF INTERMEDIATE RISK AND TREATMENT STRATEGY: MP13-17
17. PREOPERATIVE NEUTROPHIL-TO-LYMPHOCYTE RATIO IS A USEFUL BIOMARKER FOR PREDICTING WORSE CLINICAL OUTCOME IN NON-MUSCLE INVASIVE BLADDER CANCER PATIENTS WITH A PREVIOUS HISTORY OF SMOKING.: MP13-01
18. METASTATIC RENAL CELL CARCINOMA TO THE BLADDER: SYSTEMATIC REVIEW OF 113 REPORTED CASES: MP03-03
19. MP49-03 RELATIONSHIP BETWEEN INCREASED EXPRESSION OF AXL-GAS6 SIGNAL CASCADE AND PROGNOSIS IN UPPER URINARY TRACT UROTHELIAL CARCINOMA.
20. MP35-20 PLASMA FIBRINOGEN LEVEL INDEPENDENTLY PREDICTS THE PROGNOSIS OF PATIENTS WITH NON-METASTATIC RENAL CELL CARCINOMA
21. PD17-08 REFRAINING FROM SMOKING FOR 15 YEARS OR MORE REDUCED THE RISK OF TUMOR RECURRENCE IN NON-MUSCLE INVASIVE BLADDER CANCER PATIENTS
22. PD17-03 “TUMOR BUDDING”, A NOVEL PROGNOSTIC INDICATOR FOR PREDICTING STAGE PROGRESSION IN T1 BLADDER TUMORS
23. MP7-10 THE PROGNOSTIC IMPACT OF HISTONE H3K27 TRIMETHYLATION REGULATED BY EZH2 IN PATIENTS WITH UPPER URINARY TRACT UROTHELIAL CARCINOMA
24. MP2-08 URINARY PH IS HIGHLY ASSOCIATED WITH BLADDER RECURRENCE AFTER NEPHROURETERECTOMY FOR UPPER URINARY TRACT UROTHELIAL CARCINOMA PATIENTS WITH POSITIVE SMOKING HISTORY
25. THE PREDICTIVE VALUE OF C-REACTIVE PROTEIN FOR PROGNOSIS IN PATIENTS WITH METASTATIC UPPER TRACT UROTHELIAL CARCINOMA TREATED WITH CISPLATIN-BASED CHEMOTHERAPY FOLLOWING RADICAL NEPHROURETERECTOMY: MULTI-INSTITUTIONAL STUDY: MP77-19
26. OPTIMAL TIMING OF HORMONAL THERAPY FOR PROSTATE-SPECIFIC ANTIGEN RECURRENCE AFTER RADICAL PROSTATECTOMY: MP70-03
27. PROSPECTIVE EVALUATION OF EFFICACY AND SAFETY OF SOLIFENACIN AND MIRABEGRON TREATMENT IN BPH PATIENTS TREATED WITH DUTASTERIDE BUT HAVING OAB SYMPTOMS: PD23-11
28. POST-TRANSLATIONAL MODIFICATION MEDIATED BY THE PROLYL ISOMERASE PIN1 ACCERELATE CANCER PROGRESSION IN CASTRATION RESISTANT PROSTATE CANCER: MP52-20
29. TIMING OF 1ST RECURRENCE AFFECTS SUBSEQUENT CLINICAL OUTCOME IN 1ST RECURRENT LOW GRADE TA BLADDER CANCER.: MP56-12
30. IMPACT OF LYMPHOVASCULAR INVASION STATUS IN TRANSURETHRAL RESECTION OF BLADDER TUMORS COULD PREDICT SUBSEQUENT STAGE PROGRESSION IN T1 BLADDER TUMORS.: MP56-04
31. NICOTINE INDUCES TUMOR AGGRESSIVENESS AND CHEMORESISTANCE THROUGH ACTIVATION OF PI3K/AKT/MTOR PATHWAY IN BLADDER CANCER: MP34-01
32. ERECTILE FUNCTION IS HIGHLY ASSOCIATED WITH PROSTATE-SPECIFIC ANTIGEN BOUNCE IN LOCALIZED PROSTATE CANCER PATIENTS TREATED WITH PERMANENT PROSTATE BRACHYTHERAPY: MP32-11
33. INCREASED EXPRESSION OF ARYL HYDROCARBON RECEPTOR IN CLEAR CELL RENAL CELL CARCINOMA AND INFILTRATING LYMPHOCYTES: IMPLICATIONS FOR CANCER INVASION, PROGNOSIS AND TUMOR IMMUNITY: MP29-02
34. AXL IS A NOVEL PROGNOSTIC MARKER IN UPPER URINARY TRACT UROTHELIAL CARCINOM: MP28-04
35. METABOLIC SHIFT UNDER HYPOXIC ENVIRONMENT CAUSES RESISTANCE TO MTOR INHIBITOR IN HUMAN CASTRATION RESISTANT PROSTATE CANCER.: MP24-14
36. DRUG EFFICACY REPROGRAMMING BY RIBAVIRIN AGAINST THE CANCER STEMNESS IN DOCETAXEL-RESISTANT PROSTATE CANCER: MP24-10
37. THERAPEUTIC EFFECT BY TARGETING BCL-XL PROTEIN IN UROTHELIAL CARCINOMA CELLS: MP21-13
38. UP-REGULATED NFκB ACTIVATION IS A POTENT THERAPEUTIC TARGET IN ACQUIRED PLATINUM-RESISTANT BLADDER CANCER: THE EFFICACY OF NFκB BLOCKADE BY DEHYDROXYMETHYL DERIVATIVE OF EPOXYQUINOMICIN (DHMEQ): MP21-11
39. DEVELOPMENT OF AN ALGORITHM FOR PREDICTING SEVERE ACUTE EPIDIDYMITIS: MP16-18
40. CONTEMPORARY MINIMALLY INVASIVE MANAGEMENT OF ADRENAL DISORDERS: AN INTERNATIONAL MULTI-INSTITUTIONAL SURVEY: PD1-06
41. Dual PI3K/mTOR Inhibitor NVP-BEZ235 Sensitizes Docetaxel in Castration Resistant Prostate Cancer
42. Impact of Smoking Status on Bladder Tumor Recurrence After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma
43. IMPACT OF SMOKING STATUS ON BLADDER RECURRENCE FOLLOWING RADICAL NEPHROURETERECTOMY IN PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA: 897
44. LAPAROSCOPIC ADRENALECTOMY INCLUDING LESS IN PATIENTS WITH PHEOCHROMOCYTOMA: THE EVALUATION OF PERIOPERATIVE SURGICAL RISK: 51
45. PREDICTIVE VALUE OF POSITIVE URINE CYTOLOGY FOR PROGNOSIS IN PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA FOLLOWING RADICAL NEPHROURETERECTOMY: 399
46. CHARACTERISTICS AND OUTCOME IN METASTATIC UPPER TRACT UROTHELIAL CARCINOMA FOLLOWING RADICAL NEPHROURETERECTOMY: THE MULTI-INSTITUTIONAL EXPERIENCE: 398
47. PREDICTING PROSTATE SPECIFIC ANTIGEN RECURRENCE AFTER RADICAL PROSTATECTOMY BY CLINICOPATHOLOGICAL FACTORS: SUITABILITY OF MAGNETIC RESONANCE IMAGING: 240
48. A Prospective Longitudinal Survey of Erectile Dysfunction in Patients with Localized Prostate Cancer Treated with Permanent Prostate Brachytherapy
49. THERAPEUTIC EFFECT AFTER TRANSUMBILICAL LAPAROSCOPIC SINGLE-SITE ADRENALECTOMY IN PATIENTS WITH PRIMARY ALDOSTERONISM: A MATCHED CASE-CONTROL STUDY: 1019
50. PROGNOSTIC VALUE OF PLASMA FIBRINOGEN LEVELS IN PATIENTS WITH LOCALIZED UPPER TRACT UROTHELIAL CARCINOMA: 386
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.